InvestorsHub Logo
Followers 22
Posts 1020
Boards Moderated 0
Alias Born 07/23/2017

Re: None

Thursday, 07/25/2019 7:30:21 PM

Thursday, July 25, 2019 7:30:21 PM

Post# of 2676
It’s amazing to me why there is so much selling of this stock. The results of the FragileX studies are bound to be great because it’s shown so much promise already in study results already presented for 3,6,12 months on the gel patch.

1st Epilepsy trial results are coming soon and should be good as well. GW already showed that when you hit CBD receptors seizures are reduced and this should be carried out in the DEE study as well. Even with just small decrees in seizures this will be remarkable considering minimal to no side effect profile.

Plus you still have 2 or three other indications that are being studied. And no telling what will happen when it goes to studying adult Epilepsy. The sky is the limit.

Why anyone sells on Cramer’s advice is beyond me. He can’t possibly have any real expertise in this arena. Nor can he have insider info and be advising on it. Either way you look at it. Selling on his advice with what is known about this company is nonsense.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News